ADAMTS13 and cardiovascular disorder: High vWF levels, as seen in stroke and cardiovascular disease, could also be potentially mitigated by recombinant ADAMTS13 more safely than by plasma transfusion [81], thus showing the potential of this protein in biomedical applications.